10x Genomics

10x Genomics TXG Stock

$56.65   0.621674%
Add to favorites
Market Cap
$7.45B
LOW - HIGH [24H]
$55.38 - $58.22
VOLUME [24H]
$757.93K
P/E Ratio
0
Earnings per share
-$0.52
ISIN
US88025U1097
Price   Prediction

10x Genomics Price Chart

Sorry, that's all we've gotfor now...

10x Genomics (TXG) stock price today is 56.65 USD on Tech Market Large (+0.62% on the day). Updated .

10x Genomics TXG Financial and Trading Overview

10x Genomics stock price 56.65 USD
Previous Close 54.99 USD
Open 55.47 USD
Bid 39.78 USD x 200
Ask 68.9 USD x 200
Day's Range 52.67 - 56.73 USD
52 Week Range 15.18 - 102.81 USD
Volume 2.86M USD
Avg. Volume 3.4M USD
Market Cap 7.41B USD
Beta (5Y Monthly) 2.029
PE Ratio (TTM) N/A
EPS (TTM) -0.52 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 68.14 USD

TXG Valuation Measures

Enterprise Value 6.91B USD
Trailing P/E N/A
Forward P/E 649.5904
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 11.971649
Price/Book (mrq) 8.834144
Enterprise Value/Revenue 11.164
Enterprise Value/EBITDA -260.496

Trading Information

10x Genomics Stock Price History

Beta (5Y Monthly) 2.029
52-Week Change 259.74%
S&P500 52-Week Change 10.51%
52 Week High 102.81 USD
52 Week Low 15.18 USD
50-Day Moving Average 73.58 USD
200-Day Moving Average 42.93 USD

TXG Share Statistics

Avg. Volume (3 month) 3.4M USD
Avg. Daily Volume (10-Days) 3.13M USD
Shares Outstanding 121.46M
Float 119.47M
Short Ratio 3.13
% Held by Insiders 1.40%
% Held by Institutions 114.15%
Shares Short 12.47M
Short % of Float 13.85%
Short % of Shares Outstanding 9.47%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -10.84%
Operating Margin (ttm) -10.62%
Gross Margin 71.96%
EBITDA Margin -4.28%

Management Effectiveness

Return on Assets (ttm) -3.92%
Return on Equity (ttm) -8.26%

Income Statement

Revenue (ttm) 618.58M USD
Revenue Per Share (ttm) 4.8 USD
Quarterly Revenue Growth (yoy) 1.09%
Gross Profit (ttm) 445.15M USD
EBITDA -26509000 USD
Net Income Avi to Common (ttm) -67078000 USD
Diluted EPS (ttm) -0.52
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 575.68M USD
Total Cash Per Share (mrq) 4.38 USD
Total Debt (mrq) 75.79M USD
Total Debt/Equity (mrq) 9.04 USD
Current Ratio (mrq) 5.12
Book Value Per Share (mrq) 6.373

Cash Flow Statement

Operating Cash Flow (ttm) 99.7M USD
Levered Free Cash Flow (ttm) 122.82M USD

Profile of 10x Genomics

Country United States
State CA
City Pleasanton
Address 6230 Stoneridge Mall Road
ZIP 94588-3260
Phone 925 401 7300
Website https://www.10xgenomics.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 1178

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Q&A For 10x Genomics Stock

What is a current TXG stock price?

10x Genomics TXG stock price today per share is 56.65 USD.

How to purchase 10x Genomics stock?

You can buy TXG shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for 10x Genomics?

The stock symbol or ticker of 10x Genomics is TXG.

Which industry does the 10x Genomics company belong to?

The 10x Genomics industry is Medical Devices.

How many shares does 10x Genomics have in circulation?

The max supply of 10x Genomics shares is 131.53M.

What is 10x Genomics Price to Earnings Ratio (PE Ratio)?

10x Genomics PE Ratio is now.

What was 10x Genomics earnings per share over the trailing 12 months (TTM)?

10x Genomics EPS is -0.52 USD over the trailing 12 months.

Which sector does the 10x Genomics company belong to?

The 10x Genomics sector is Healthcare.

10x Genomics TXG included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24447.41 USD —
+0.49
4.72B USD — 24225.3 USD — 24538.78 USD — — 4.72B USD —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3643.19 USD —
+0.54
— — 3611.7 USD — 3667.39 USD — — — —
us US Tech Global Select Market Com NQGS US 11980.52 USD —
-0.03
— — 11954.49 USD — 12087.35 USD — — — —
us US Tech Next Generation 100 Inde NGX US 1700.95 USD —
+0.54
— — 1684.48 USD — 1709.46 USD — — — —
us US Tech Health Care IXHC US 1324.94 USD —
-0.6
— — 1322.85 USD — 1342.46 USD — — — —
$2.17T
Total marketcap
$71.2B
Total volume
BTC 58.08%   •   ETH 9.88%
Dominance
Select currency